COMPARISON BETWEEN SIMVASTATIN AND BEZAFIBRATE IN EFFECT ON PLASMA LIPOPROTEINS AND APOLIPOPROTEINS IN PRIMARY HYPERCHOLESTEROLAEMIA

The Metabolic Basis of Inherited Disease.

Annals of Internal Medicine · 1988 · 7.8K citations

Metabolic Syndrome, Energy Metabolism, Disease Mechanism +12

Effects of an Inhibitor of 3-Hydroxy-3-Methylglutaryl Coenzyme a Reductase on Serum Lipoproteins and Ubiquinone-10 Levels in Patients with Familial Hypercholesterolemia

Hiroshi Mabuchi, Toshihiro Haba, RYZO TATAMI et al. · New England Journal of Medicine · 1981 · 262 citations

Therapeutic effects of ML-236B in primary hypercholesterolemia

Akira Yamamoto, Hiroshi Sudo, Akira Endo · Atherosclerosis · 1980 · 232 citations

Metabolic Syndrome, Primary Hypercholesterolemia, Lipid Disorder +8

EFFECTS OF SYNVINOLIN (MK-733) ON PLASMA LIPIDS IN FAMILIAL HYPERCHOLESTEROLAEMIA

M.J.T.M. Mol, J.A. Gevers Leuven, D.W. Erkelens et al. · The Lancet · 1986 · 156 citations

Metabolic Syndrome, Lipid Disorder, Effects Of Synvinolin +4

Effects of clofibrate, bezafibrate, fenofibrate and probucol on plasma lipolytic enzymes in normolipaemic subjects

F. Heller, C. Harvengt · European Journal of Clinical Pharmacology · 1983 · 138 citations

Lipid Analysis, Metabolic Syndrome, Lipid Disorder +11